Search clinical trials for: Asthma, Children, Prevention, Severe Asthma Exacerbations

Total 16659 results

Neutec Ar-Ge San ve Tic A.Ş

Completed

Comparison of 24 Hour Bronchodilator Efficacy of Tiotropium 18 mcg Delivered Via DISCAIR Versus SPIRIVA 18 µg Delivered Via HANDIHALER® in Patients With Moderate to Severe COPD

COPD
Neutec Ar-Ge San ve Tic A.Ş

Completed

Efficacy and Safety Study of Acetylcysteine/Doxofylline 1200/400 mg Effervescent Tablet in the Treatment of Moderate-Severe COPD.

COPD

Turkey
University of Nottingham

Unknown

Impact of Asthma Exacerbations (IMPAX)

Asthma Attack

United Kingdom
Adana Numune Training and Research Hospital

Completed

Atopic Diseases & Human Papilloma Virus

Human Papilloma Virus | Atopic Asthma | Atopic Disorders

Turkey
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.

Asthma

Germany, United States, Belgium, Poland, Romania, Estonia, Australia, Austria, France, Switzerland, United Kingdom, Latvia, Lithuania, Guatemala, Brazil, Argentina, Philippines, China, Singapore, Finland, Hungary, Greece, Ireland, Vie... and more
Amgen

Completed

Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)

Psoriasis | Plaque-type Psoriasis

United States, Canada
University of Edinburgh
NHS Lothian

Completed

Bacterial Load Guided Therapy for Severe Bronchiectasis Exacerbations (BLTBrIV)

Bronchiectasis

United Kingdom
Nicholas Kenyon
National Heart, Lung, and Blood Institute (NHLBI)

Completed

L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Levels

Inflammation | Asthma

United States
Pfizer

Completed

Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis (JADE Mono-2)

Dermatitis, Atopic

China, United States, Australia, Poland, Hungary, Korea, Republic of, Germany, Bulgaria, Canada, Czechia, Japan, Latvia, United Kingdom
NHS Greater Glasgow and Clyde
Queen's University, Belfast

Completed

Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma (MAPLE)

Asthma

United Kingdom
GlaxoSmithKline

Completed

Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma

Asthma

United States, Canada, Russian Federation, Mexico, Australia, Ukraine
Pontificia Universidade Católica do Rio Grande...

Completed

Effects of CPAP in Severe Therapy-resistant Asthma (CPAP-STRA)

Asthma

Brazil
Fundació Institut de Recerca de l'Hospital de la...
Universidad de Zaragoza

Completed

Autonomic Nervous System Role in Uncontrolled ASTHMA and the Paucigranulocitic Phenotype (ANASTHMA)

Asthma

Spain
Novartis Pharmaceuticals

Completed

A Long-term Safety Study of QMF149 in Japanese Participants With Asthma

Asthma

Japan
GlaxoSmithKline

Completed

Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients

Asthma

United States, Argentina, Australia, Canada, France, Germany, Japan, Korea, Republic of, Netherlands, Poland, Romania, Russian Federation, Spain, Ukraine
University of Sao Paulo General Hospital

Unknown

A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil

Eosinophilic Asthma

Brazil
University of Wisconsin, Madison

Completed

Asthma and Obstructive Sleep Apnea (OSA)

Asthma | Obstructive Sleep Apnea

United States
GlaxoSmithKline

Completed

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

Asthma

United States, Argentina, Australia, Canada, France, Germany, Japan, Netherlands, Poland, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, Czechia, Italy, United Kingdom
Imperial College London
Royal Brompton & Harefield NHS Foundation Trust

Completed

Prednisolone Pharmacokinetics in Severe Asthma

Asthma

United Kingdom
AstraZeneca

Completed

A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation (SOLANA)

Asthma

United States, Germany, Korea, Republic of, Philippines, Hungary, Chile
Imperial College London
Vectura Limited

Completed

In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma

Asthma

United Kingdom
Imperial College London
Medical Research Council; Royal Brompton & Harefield NHS Foundation Trust

Completed

p38 Mitogen-Activated Protein Kinase (MAPK) and Steroid Insensitivity in Asthma

Asthma

United Kingdom
Medical University of Warsaw

Completed

BIOmarkers in Severe AsthMa Patients on Omalizumab Treatment (BIOSAMOT)

Severe Asthma

Poland
Imperial College London
National Institutes of Health (NIH)

Completed

Inflammation and Corticosteroid Responsiveness in Severe Asthma (SARP)

Asthma

United Kingdom
Virginia Commonwealth University

Completed

Kids 2 Be & Breathe: A Study on the Use of Yoga and Mindfulness in Children With Severe Asthma (K2B2) (K2B2)

Asthma

United States
Sanofi
Regeneron Pharmaceuticals

Completed

Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma (VENTURE)

Asthma

Belgium, Israel, United States, Mexico, Argentina, Brazil, Canada, Chile, Colombia, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, Ukraine
Pearl Therapeutics, Inc.

Completed

Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD (telos)

Chronic Obstructive Pulmonary Disorder

United States, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Czechia
Attikon Hospital

Unknown

Mepolizumab: Real World Evidence Study for the Treatment of Severe Eosinophilic Asthma in Greece

Severe Eosinophilic Asthma
Chiesi Farmaceutici S.p.A.
Atopix Therapeutics, Ltd.

Completed

Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma

Severe Eosinophilic Asthma

United Kingdom
Children's Hospital of Philadelphia

Completed

Aerosolized Albuterol Use in Severe BPD

Severe Bronchopulmonary Dysplasia

United States
Xemed LLC
Washington University School of Medicine; National Heart, Lung, and Blood Institute... and other collaborators

Completed

Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI (HXe-BT)

Asthma

United States
Beaumont Hospital

Unknown

Inhaler Adherence in Severe Unstable Asthma (INCA-SUN)

Asthma

Ireland
Guy's and St Thomas' NHS Foundation Trust
King's College London; National Institute for Health Research, United Kingdom

Completed

Role of Anti-IgE in Severe Childhood Eczema (ADAPT)

Child | Atopic Dermatitis | Atopic Eczema

United Kingdom
Novartis Pharmaceuticals

Completed

A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPD

Chronic Obstructive Pulmonary Disease

Germany, Poland, Romania, Hungary, Sweden, Russian Federation, Bulgaria, Finland, Israel, Belgium
Assistance Publique - Hôpitaux de Paris

Completed

Dupilumab for Severe Asthma in a Real Life Setting (DUPI-France)

Severe Asthma

France
AstraZeneca

Completed

Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

China
TC Erciyes University

Completed

Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe Asthma

Chronic Rhinosinusitis (Diagnosis) | Eosinophilic Asthma | Asthma, Allergic | Asthma Persistent

Turkey
University of Monastir

Unknown

Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma

Acute Asthma

Tunisia
University Medical Center Groningen

Unknown

Symptom-driven Maintenance and Reliever Treatment to Prevent Exacerbations in COPD

COPD

Netherlands
Queen's University, Belfast
Medical Research Council; University of Oxford; Belfast Health and Social Care... and other collaborators

Completed

Exploring Asthma Exacerbations in Mepolizumab Treated Patients

Asthma Brittle

United Kingdom
AstraZeneca

Completed

Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients (SECURE2)

Chronic Obstructive Pulmonary Disease (COPD)

China
The Hospital for Sick Children

Completed

Dynamic Contrast Enhanced Magnetic Resonance Perfusion Imaging in Congenital Heart Disease and Lung Disease

Asthma | Cystic Fibrosis | Heart Disease

Canada
Academisch Medisch Centrum - Universiteit van Amsterdam...
University Medical Center Groningen

Active, not recruiting

Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study

Severe Asthma

Netherlands
Novartis Pharmaceuticals

Terminated

Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma (MEXIC)

Severe IgE-mediated Asthma

Mexico
AstraZeneca
MedImmune LLC

Completed

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History (TERRANOVA)

Moderate to Very Severe Chronic Obstructive Pulmonary Disease

United States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
University of Pennsylvania
Patient-Centered Outcomes Research Institute

Completed

Using IT to Improve Access, Communication and Asthma in African American and Hispanic/Latino Adults

Asthma | Communication

United States
AstraZeneca
MedImmune LLC

Completed

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History (GALATHEA)

Moderate to Very Severe Chronic Obstructive Pulmonary Disease

United States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
Pfizer

Terminated

An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

Asthma

United States
Laval University
Novartis

Completed

Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD (RED)

COPD

Canada
AstraZeneca
Parexel International Ltd; Cognizant Technology Solution; Center for Information... and other collaborators

Completed

Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (AERISTO)

Chronic Obstructive Pulmonary Disease COPD

United States, Canada, France, Russian Federation, Ukraine, Hungary, Bulgaria

Search clinical trials for: Asthma, Children, Prevention, Severe Asthma Exacerbations

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations